BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reimer P, Rummeny EJ, Daldrup HE, Balzer T, Tombach B, Berns T, Peters PE. Clinical results with Resovist: a phase 2 clinical trial. Radiology. 1995;195:489-496. [PMID: 7724772 DOI: 10.1148/radiology.195.2.7724772] [Cited by in Crossref: 136] [Cited by in F6Publishing: 110] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Geraldes CF, Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 2009;4:1-23. [PMID: 19156706 DOI: 10.1002/cmmi.265] [Cited by in Crossref: 371] [Cited by in F6Publishing: 300] [Article Influence: 28.5] [Reference Citation Analysis]
2 Carvalho PM, Felício MR, Santos NC, Gonçalves S, Domingues MM. Application of Light Scattering Techniques to Nanoparticle Characterization and Development. Front Chem 2018;6:237. [PMID: 29988578 DOI: 10.3389/fchem.2018.00237] [Cited by in Crossref: 79] [Cited by in F6Publishing: 55] [Article Influence: 19.8] [Reference Citation Analysis]
3 Zhu L, Zhou Z, Mao H, Yang L. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy. Nanomedicine (Lond) 2017;12:73-87. [PMID: 27876448 DOI: 10.2217/nnm-2016-0316] [Cited by in Crossref: 113] [Cited by in F6Publishing: 77] [Article Influence: 18.8] [Reference Citation Analysis]
4 Jun Y, Jang J, Cheon J. Magnetic Nanoparticle Assisted Molecular MR Imaging. In: Chan WCW, editor. Bio-Applications of Nanoparticles. New York: Springer; 2007. pp. 85-106. [DOI: 10.1007/978-0-387-76713-0_7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
5 Murakami T, Imai Y, Okada M, Hyodo T, Lee WJ, Kim MJ, Kim T, Choi BI. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions. Oncology. 2011;81 Suppl 1:86-99. [PMID: 22212941 DOI: 10.1159/000333267] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
6 Ohki A, Saito S, Fukuchi K. Magnetic resonance imaging of umbilical cord stem cells labeled with superparamagnetic iron oxide nanoparticles: effects of labelling and transplantation parameters. Sci Rep. 2020;10:13684. [PMID: 32792506 DOI: 10.1038/s41598-020-70291-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
7 Jun Y, Lee J, Cheon J. Chemical Design of Nanoparticle Probes for High‐Performance Magnetic Resonance Imaging. Angew Chem Int Ed 2008;47:5122-35. [DOI: 10.1002/anie.200701674] [Cited by in Crossref: 704] [Cited by in F6Publishing: 608] [Article Influence: 50.3] [Reference Citation Analysis]
8 Jung G, Krahe T, Kugel H, Gieseke J, Walter C, Lackner K. Detection of Focal Hepatic Lesions: Effects of Superparamagnetic Iron Oxide (AMI-25) on Magnetic Resonance Imaging of the Liver Using T2-Weighted Fast Spin-Echo Sequences and Gradient-and-Spin-Echo Sequences at 1.0 Tesla. INVESTIGATIVE RADIOLOGY 1998;33:61-7. [DOI: 10.1097/00004424-199802000-00001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
9 Fukukura Y, Kamiyama T, Takumi K, Shindo T, Higashi R, Nakajo M. Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions. J Magn Reson Imaging 2010;31:607-16. [PMID: 20187203 DOI: 10.1002/jmri.22098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Daldrup-Link HE, Chan C, Lenkov O, Taghavigarmestani S, Nazekati T, Nejadnik H, Chapelin F, Khurana A, Tong X, Yang F, Pisani L, Longaker M, Gambhir SS. Detection of Stem Cell Transplant Rejection with Ferumoxytol MR Imaging: Correlation of MR Imaging Findings with Those at Intravital Microscopy. Radiology 2017;284:495-507. [PMID: 28128708 DOI: 10.1148/radiol.2017161139] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
11 Parsa H, Shamsasenjan K, Movassaghpour A, Akbarzadeh P, Amoghli Tabrizi B, Dehdilani N, Lotfinegad P, Soleimanloo F. Effect of Superparamagnetic Iron Oxide Nanoparticles-Labeling on Mouse Embryonic Stem Cells. Cell J 2015;17:221-30. [PMID: 26199901 DOI: 10.22074/cellj.2016.3719] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Nejadnik H, Lenkov O, Gassert F, Fretwell D, Lam I, Daldrup-Link HE. Macrophage phagocytosis alters the MRI signal of ferumoxytol-labeled mesenchymal stromal cells in cartilage defects. Sci Rep 2016;6:25897. [PMID: 27174199 DOI: 10.1038/srep25897] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
13 Nuzhina JV, Shtil AA, Prilepskii AY, Vinogradov VV. Preclinical Evaluation and Clinical Translation of Magnetite-Based Nanomedicines. Journal of Drug Delivery Science and Technology 2019;54:101282. [DOI: 10.1016/j.jddst.2019.101282] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Van Beers BE, Goudemant J, Øksendal A, Jamart J, Delos M, Thiran J, Demeure R, Pringot J, Maldague B. Detection of reperfused ischemia of the rat intestine: value of magnetic resonance imaging with small-molecular-weight dysprosium and gadolinium chelates. Academic Radiology 1997;4:35-42. [DOI: 10.1016/s1076-6332(97)80159-6] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
15 Kaplan JA, Grinstaff MW, Bloch BN. Polymer film-nanoparticle composites as new multimodality, non-migrating breast biopsy markers. Eur Radiol 2016;26:866-73. [DOI: 10.1007/s00330-015-3852-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Kim JI, Chun C, Kim B, Hong JM, Cho J, Lee SH, Song S. Thermosensitive/magnetic poly(organophosphazene) hydrogel as a long-term magnetic resonance contrast platform. Biomaterials 2012;33:218-24. [DOI: 10.1016/j.biomaterials.2011.09.033] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 7.5] [Reference Citation Analysis]
17 Xu F, Cheng C, Chen DX, Gu H. Magnetite nanocrystal clusters with ultra-high sensitivity in magnetic resonance imaging. Chemphyschem 2012;13:336-41. [PMID: 22095763 DOI: 10.1002/cphc.201100548] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
18 Laconte L, Nitin N, Bao G. Magnetic nanoparticle probes. Materials Today 2005;8:32-8. [DOI: 10.1016/s1369-7021(05)00893-x] [Cited by in Crossref: 127] [Article Influence: 7.5] [Reference Citation Analysis]
19 Tong W, Hui H, Shang W, Zhang Y, Tian F, Ma Q, Yang X, Tian J, Chen Y. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles. Theranostics 2021;11:506-21. [PMID: 33391489 DOI: 10.7150/thno.49812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Doerfler A, Engelhorn T, Heiland S, Knauth M, Wanke I, Forsting M. MR contrast agents in acute experimental cerebral ischemia: potential adverse impacts on neurologic outcome and infarction size. J Magn Reson Imaging 2000;11:418-24. [PMID: 10767071 DOI: 10.1002/(sici)1522-2586(200004)11:4<418::aid-jmri10>3.0.co;2-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Daniele Marin, Iannaccone R, Laghi A, Catalano C, Murakami T, Hori M, Kim T, Passariello R. Focal nodular hyperplasia: Intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging 2007;25:775-82. [DOI: 10.1002/jmri.20885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
22 Reimer P, Allkemper T, Bremer C, Rummeny EJ, Spiegel HU, Balzer T, Peters PE. Assessment of reperfusion injury by means of MR contrast agents in rat liver. J Magn Reson Imaging 1997;7:490-4. [DOI: 10.1002/jmri.1880070307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
23 Kato N, Takahashi M, Tsuji T, Ihara S, Brautigam M, Miyazawa T. Dose-Dependency and Rate of Decay of Efficacy of Resovist on MR Images in a Rat Cirrhotic Liver Model: . Investigative Radiology 1999;34:551. [DOI: 10.1097/00004424-199909000-00001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
24 Kooi M, Heeneman S, Daemen M, Engelshoven JV, Cleutjens K. The Emerging Role of USPIOs for MR Imaging of Atherosclerosis. In: Bulte JW, Modo MM, editors. Nanoparticles in Biomedical Imaging. New York: Springer; 2008. pp. 63-90. [DOI: 10.1007/978-0-387-72027-2_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999;210:459-66. [PMID: 10207430 DOI: 10.1148/radiology.210.2.r99fe05459] [Cited by in Crossref: 187] [Cited by in F6Publishing: 158] [Article Influence: 8.1] [Reference Citation Analysis]
26 Schnorr J, Taupitz M, Wagner S, Pilgrimm H, Hansel J, Hamm B. Age-related blood half-life of particulate contrast material: experimental results with a USPIO in rats. J Magn Reson Imaging 2000;12:740-4. [PMID: 11050644 DOI: 10.1002/1522-2586(200011)12:5<740::aid-jmri11>3.0.co;2-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
27 Kehagias DT, Gouliamos AD, Smyrniotis V, Vlahos LJ. Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 2001;14:595-601. [DOI: 10.1002/jmri.1224] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
28 Low RN. Contrast agents for MR imaging of the liver. J Magn Reson Imaging 1997;7:56-67. [DOI: 10.1002/jmri.1880070109] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
29 Reimer P, Marx C, Rummeny EJ, Müller M, Lentschig M, Balzer T, Dietl K, Sulkowski U, Berns T, Shamsi K, Peters PE. SPIO-enhanced 2D-TOF MR angiography of the portal venous system: Results of an intraindividual comparison. J Magn Reson Imaging 1997;7:945-9. [DOI: 10.1002/jmri.1880070602] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
30 Ba-Ssalamah A, Heinz-Peer G, Schima W, Schibany N, Schick S, Prokesch RW, Kaider A, Teleky B, Wrba F, Lechner G. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 2000;11:665-72. [PMID: 10862066 DOI: 10.1002/1522-2586(200006)11:6<665::aid-jmri13>3.0.co;2-d] [Cited by in Crossref: 45] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Earls JP, Bluemke DA. NEW MR IMAGING CONTRAST AGENTS. Magnetic Resonance Imaging Clinics of North America 1999;7:255-73. [DOI: 10.1016/s1064-9689(21)00021-0] [Cited by in Crossref: 20] [Article Influence: 0.9] [Reference Citation Analysis]
32 Kato H, Kanematsu M, Kondo H, Goshima S, Matsuo M, Hoshi H, Moriyama N. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity. J Magn Reson Imaging. 2004;19:76-81. [PMID: 14696223 DOI: 10.1002/jmri.10425] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
33 Allkemper T, Bremer C, Matuszewski L, Ebert W, Reimer P. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. Radiology 2002;223:432-8. [PMID: 11997549 DOI: 10.1148/radiol.2232010241] [Cited by in Crossref: 98] [Cited by in F6Publishing: 94] [Article Influence: 4.9] [Reference Citation Analysis]
34 Siegelman ES, Outwater EK. Magnetic resonance imaging of focal and diffuse hepatic disease. Seminars in Ultrasound, CT and MRI 1998;19:2-34. [DOI: 10.1016/s0887-2171(98)90022-1] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
35 Briley-saebo KC, Johansson LO, Hustvedt SO, Haldorsen AG, Bj??rnerud A, Fayad ZA, Ahlstrom HK. Clearance of Iron Oxide Particles in Rat Liver: Effect of Hydrated Particle Size and Coating Material on Liver Metabolism. Investigative Radiology 2006;41:560-71. [DOI: 10.1097/01.rli.0000221321.90261.09] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 4.4] [Reference Citation Analysis]
36 Daldrup-Link HE. Ten Things You Might Not Know about Iron Oxide Nanoparticles. Radiology. 2017;284:616-629. [PMID: 28825888 DOI: 10.1148/radiol.2017162759] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 14.4] [Reference Citation Analysis]
37 Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Invest Radiol 1996;31:696-708. [PMID: 8915751 DOI: 10.1097/00004424-199611000-00004] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 3.0] [Reference Citation Analysis]
38 Paolini A, Guarch CP, Ramos-López D, de Lapuente J, Lascialfari A, Guari Y, Larionova J, Long J, Nano R. Rhamnose-coated superparamagnetic iron-oxide nanoparticles: an evaluation of their in vitro cytotoxicity, genotoxicity and carcinogenicity. J Appl Toxicol 2016;36:510-20. [PMID: 26708321 DOI: 10.1002/jat.3273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
39 Park HS, Lee JM, Kim SH, Chang S, Kim SJ, Han JK, Choi BI. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla. J Magn Reson Imaging. 2009;29:328-335. [PMID: 19161184 DOI: 10.1002/jmri.21615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
40 Sugihara S, Suto Y, Yoshida K. Optimum conditions for iron colloid enhanced fast spin echo imaging in hepatocellular carcinoma. Br J Radiol 1997;70:791-7. [PMID: 9486042 DOI: 10.1259/bjr.70.836.9486042] [Reference Citation Analysis]
41 Ichikawa T, Araki T. Fast magnetic resonance imaging of liver. Eur J Radiol. 1999;29:186-210. [PMID: 10399607 DOI: 10.1016/s0720-048x(98)00176-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
42 Reimer P, Müller M, Marx C, Balzer T. Evaluation of the Time Window for Resovist-Enhanced T2-Weighted MRI of the Liver. Academic Radiology 2002;9:S336-8. [DOI: 10.1016/s1076-6332(03)80222-2] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
43 Matsuo M, Kanematsu M, Itoh K, Ito K, Maetani Y, Kondo H, Kako N, Matsunaga N, Hoshi H, Shiraishi J. Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging. AJR Am J Roentgenol. 2001;177:637-643. [PMID: 11517061 DOI: 10.2214/ajr.177.3.1770637] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
44 Ward J, Chen F, Guthrie JA, Wilson D, Lodge JP, Wyatt JI, Robinson PJ. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology. 2000;214:159-166. [PMID: 10644117 DOI: 10.1148/radiology.214.1.r00ja21159] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 2.6] [Reference Citation Analysis]
45 Soyer P, Bluemke DA, Rymer R. MR IMAGING OF THE LIVER. Magnetic Resonance Imaging Clinics of North America 1997;5:205-21. [DOI: 10.1016/s1064-9689(21)00193-8] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
46 Chanyaputhipong J, Low SC, Chow PK. Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians. Int J Hepatol. 2011;2011:489342. [PMID: 21994860 DOI: 10.4061/2011/489342] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
47 Abdollah MR, Kalber T, Tolner B, Southern P, Bear JC, Robson M, Pedley RB, Parkin IP, Pankhurst QA, Mulholland P, Chester K. Prolonging the circulatory retention of SPIONs using dextran sulfate: in vivo tracking achieved by functionalisation with near-infrared dyes. Faraday Discuss 2014;175:41-58. [PMID: 25298115 DOI: 10.1039/c4fd00114a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
48 Lu CW, Hsiao JK, Liu HM, Wu CH. Characterization of an iron oxide nanoparticle labelling and MRI-based protocol for inducing human mesenchymal stem cells into neural-like cells. Sci Rep. 2017;7:3587. [PMID: 28620162 DOI: 10.1038/s41598-017-03863-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
49 Katayama M, Masui T, Kobayashi S, Ito T, Takahashi M, Sakahara H, Nozaki A, Kabasawa H. Fat-suppressed T2-weighted MRI of the liver: Comparison of respiratory-triggered fast spin-echo, breath-hold single-shot fast spin-echo, and breath-hold fast-recovery fast spin-echo sequences. J Magn Reson Imaging 2001;14:439-49. [DOI: 10.1002/jmri.1205] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
50 von Falkenhausen M, Meyer C, Lutterbey G, Morakkabati N, Walter O, Gieseke J, Blömer R, Willinek WA, Kuhl CK, Schild HH. Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T. Eur Radiol 2007;17:1256-61. [PMID: 17171512 DOI: 10.1007/s00330-006-0484-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
51 Lee JH, Kim JW, Cheon J. Magnetic nanoparticles for multi-imaging and drug delivery. Mol Cells 2013;35:274-84. [PMID: 23579479 DOI: 10.1007/s10059-013-0103-0] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 6.2] [Reference Citation Analysis]
52 Axmann C, Bohndorf K, Gellissen J, Prescher A, Lodemann K. Mechanisms of Accumulation of Small Particles of Iron Oxide in Experimentally Induced Osteosarcomas of Rats: A Correlation of Magnetic Resonance Imaging and Histology: Preliminary Results. Investigative Radiology 1998;33:236-45. [DOI: 10.1097/00004424-199804000-00007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
53 Reimer P, Bremer C, Allkemper T, Engelhardt M, Mahler M, Ebert W, Tombach B. Myocardial Perfusion and MR Angiography of Chest with SH U 555 C: Results of Placebo-controlled Clinical Phase I Study. Radiology 2004;231:474-81. [DOI: 10.1148/radiol.2312021251] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
54 Kirchin MA, Runge VM. Contrast Agents for Magnetic Resonance Imaging: Safety Update. Topics in Magnetic Resonance Imaging 2003;14:426-35. [DOI: 10.1097/00002142-200310000-00007] [Cited by in Crossref: 128] [Cited by in F6Publishing: 91] [Article Influence: 6.7] [Reference Citation Analysis]
55 Mclachlan SJ, Morris M, Lucas MA, Baum LM. Preliminary clinical experience with AMI 227. Academic Radiology 1996;3:S295-6. [DOI: 10.1016/s1076-6332(96)80561-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Sulek S, Mammadov B, Mahcicek DI, Sozeri H, Atalar E, Tekinay AB, Guler MO. Peptide functionalized superparamagnetic iron oxide nanoparticles as MRI contrast agents. J Mater Chem 2011;21:15157. [DOI: 10.1039/c1jm11387a] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
57 Hapuarachchige S, Kato Y, Ngen EJ, Smith B, Delannoy M, Artemov D. Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells. PLoS One 2016;11:e0156294. [PMID: 27244470 DOI: 10.1371/journal.pone.0156294] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
58 Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology. 2001;218:27-38. [PMID: 11152776 DOI: 10.1148/radiology.218.1.r01ja2427] [Cited by in Crossref: 239] [Cited by in F6Publishing: 197] [Article Influence: 11.4] [Reference Citation Analysis]
59 Nosrati H, Salehiabar M, Davaran S, Ramazani A, Manjili HK, Danafar H. New advances strategies for surface functionalization of iron oxide magnetic nano particles (IONPs). Res Chem Intermed 2017;43:7423-42. [DOI: 10.1007/s11164-017-3084-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 9.6] [Reference Citation Analysis]
60 Huang Z, Shen Y, Pei N, Sun A, Xu J, Song Y, Huang G, Sun X, Zhang S, Qin Q. The effect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation. Biomaterials. 2013;34:9905-9916. [PMID: 24055521 DOI: 10.1016/j.biomaterials.2013.08.092] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
61 Chen D, Sanchez A, Taboada E, Roig A, Sun N, Gu H. Size determination of superparamagnetic nanoparticles from magnetization curve. Journal of Applied Physics 2009;105:083924. [DOI: 10.1063/1.3117512] [Cited by in Crossref: 71] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
62 Reimer P, Allkemper T, Matuszewski L, Balzer T. Contrast-enhanced 3D-MRA of the upper abdomen with a bolus-injectable SPIO (SH U 555 A). J Magn Reson Imaging 1999;10:65-71. [DOI: 10.1002/(sici)1522-2586(199907)10:1<65::aid-jmri9>3.0.co;2-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Lartigue L, Innocenti C, Kalaivani T, Awwad A, Sanchez Duque MDM, Guari Y, Larionova J, Guérin C, Montero JG, Barragan-montero V, Arosio P, Lascialfari A, Gatteschi D, Sangregorio C. Water-Dispersible Sugar-Coated Iron Oxide Nanoparticles. An Evaluation of their Relaxometric and Magnetic Hyperthermia Properties. J Am Chem Soc 2011;133:10459-72. [DOI: 10.1021/ja111448t] [Cited by in Crossref: 189] [Cited by in F6Publishing: 166] [Article Influence: 17.2] [Reference Citation Analysis]
64 Wang AZ, Gu FX, Farokhzad OC. Nanoparticles for Cancer Diagnosis and Therapy. In: Webster TJ, editor. Safety of Nanoparticles. New York: Springer; 2009. pp. 209-35. [DOI: 10.1007/978-0-387-78608-7_10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
65 Reimer P, Jähnke N, Fiebich M, Schima W, Deckers F, Marx C, Holzknecht N, Saini S. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology. 2000;217:152-158. [PMID: 11012438 DOI: 10.1148/radiology.217.1.r00oc31152] [Cited by in Crossref: 141] [Cited by in F6Publishing: 122] [Article Influence: 6.4] [Reference Citation Analysis]
66 Imam K, Bluemke DA. MR IMAGING IN THE EVALUATION OF HEPATIC METASTASES. Magnetic Resonance Imaging Clinics of North America 2000;8:741-56. [DOI: 10.1016/s1064-9689(21)00641-3] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
67 Bremer C, Allkemper T, Baermig J, Reimer P. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography. J Magn Reson Imaging 1999;10:461-7. [DOI: 10.1002/(sici)1522-2586(199909)10:3<461::aid-jmri30>3.0.co;2-5] [Cited by in Crossref: 27] [Article Influence: 1.2] [Reference Citation Analysis]
68 Lindemann A, Lüdtke-Buzug K, Fräderich BM, Gräfe K, Pries R, Wollenberg B. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells. Int J Nanomedicine 2014;9:5025-40. [PMID: 25378928 DOI: 10.2147/IJN.S63873] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
69 Sun N, Chen D, Gu H, Wang X. Experimental study on relaxation time of protons in water suspensions of iron-oxide nanoparticles: Waiting time dependence. Journal of Magnetism and Magnetic Materials 2009;321:2971-5. [DOI: 10.1016/j.jmmm.2009.04.073] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
70 Kato N, Ihara S, Tsujimoto T, Miyazawa T. Effect of Resovist on Rats With Different Severities of Liver Cirrhosis: . Investigative Radiology 2002;37:292-8. [DOI: 10.1097/00004424-200205000-00007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
71 Moonen RP, van der Tol P, Hectors SJ, Starmans LW, Nicolay K, Strijkers GJ. Spin-lock MR enhances the detection sensitivity of superparamagnetic iron oxide particles. Magn Reson Med 2015;74:1740-9. [PMID: 25470118 DOI: 10.1002/mrm.25544] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
72 Nejadnik H, Pandit P, Lenkov O, Lahiji AP, Yerneni K, Daldrup-Link HE. Ferumoxytol Can Be Used for Quantitative Magnetic Particle Imaging of Transplanted Stem Cells. Mol Imaging Biol 2019;21:465-72. [PMID: 30194566 DOI: 10.1007/s11307-018-1276-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
73 Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
74 Tombach B, Reimer P, Bremer C, Allkemper T, Engelhardt M, Mahler M, Ebert W, Heindel W. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study. NMR Biomed 2004;17:500-6. [DOI: 10.1002/nbm.906] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
75 Balzer T, Carter EC, Shamsi K, Niendorf HP. Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver. Acad Radiol 1996;3 Suppl 2:S417-9. [PMID: 8796619 DOI: 10.1016/s1076-6332(96)80603-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
76 Chen F, Ward J, Robinson P. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents. Magnetic Resonance Imaging 1999;17:549-56. [DOI: 10.1016/s0730-725x(98)00193-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
77 Thode K, Lück M, Semmler W, Müller RH, Kresse M. Determination of plasma protein adsorption on magnetic iron oxides: sample preparation. Pharm Res 1997;14:905-10. [PMID: 9244148 DOI: 10.1023/a:1012104017761] [Cited by in Crossref: 56] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
78 Tanimoto A, Satoh Y, Yuasa Y, Jinzaki M, Hiramatsu K. Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: A comparative study by alternative free-response receiver operating characteristic analysis. J Magn Reson Imaging 1997;7:120-4. [DOI: 10.1002/jmri.1880070116] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
79 Marques MRC, Choo Q, Ashtikar M, Rocha TC, Bremer-Hoffmann S, Wacker MG. Nanomedicines - Tiny particles and big challenges. Adv Drug Deliv Rev 2019;151-152:23-43. [PMID: 31226397 DOI: 10.1016/j.addr.2019.06.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
80 Villaraza AJ, Bumb A, Brechbiel MW. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev 2010;110:2921-59. [PMID: 20067234 DOI: 10.1021/cr900232t] [Cited by in Crossref: 466] [Cited by in F6Publishing: 408] [Article Influence: 38.8] [Reference Citation Analysis]
81 Benderbous S, Corot C, Jacobs P, Bonnemain B. Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation. Acad Radiol 1996;3 Suppl 2:S292-4. [PMID: 8796583 DOI: 10.1016/s1076-6332(96)80560-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
82 Yang H, Zhou H, Zhang C, Li X, Hu H, Wu H, Yang S. Water-soluble magnetic CoO nanocrystals functionalized with surfactants as T2-weighed MRI contrast agents in vitro. Dalton Trans 2011;40:3616. [DOI: 10.1039/c1dt10107b] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
83 Jun Y, Lee J, Cheon J. Chemisches Design von leistungsfähigen Nanosonden für die Kernspintomographie. Angew Chem 2008;120:5200-13. [DOI: 10.1002/ange.200701674] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
84 Sugihara S, Suto Y, Kamba M, Ogawa T. Comparison of various techniques of iron oxide-enhanced breath-hold MR imaging of hepatocellular carcinoma. Clinical Imaging 2001;25:104-9. [DOI: 10.1016/s0899-7071(01)00252-2] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
85 Hong R, Feng B, Chen L, Liu G, Li H, Zheng Y, Wei D. Synthesis, characterization and MRI application of dextran-coated Fe3O4 magnetic nanoparticles. Biochemical Engineering Journal 2008;42:290-300. [DOI: 10.1016/j.bej.2008.07.009] [Cited by in Crossref: 218] [Cited by in F6Publishing: 141] [Article Influence: 15.6] [Reference Citation Analysis]
86 Woltz S, Hiergeist R, Görnert P, Rüssel C. Magnetite nanoparticles prepared by the glass crystallization method and their physical properties. Journal of Magnetism and Magnetic Materials 2006;298:7-13. [DOI: 10.1016/j.jmmm.2005.02.067] [Cited by in Crossref: 57] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
87 Kondo H, Kanematsu M, Hoshi H, Murakami T, Kim T, Hori M, Matsuo M, Nakamura H. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. AJR Am J Roentgenol. 2000;174:947-954. [PMID: 10749228 DOI: 10.2214/ajr.174.4.1740947] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
88 Starmans LW, Burdinski D, Haex NP, Moonen RP, Strijkers GJ, Nicolay K, Grüll H. Iron oxide nanoparticle-micelles (ION-micelles) for sensitive (molecular) magnetic particle imaging and magnetic resonance imaging. PLoS One 2013;8:e57335. [PMID: 23437371 DOI: 10.1371/journal.pone.0057335] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
89 Grazioli L, Morana G, Caudana R, Benetti A, Portolani N, Talamini G, Colombari R, Pirovano G, Kirchin MA, Spinazzi A. Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings. Invest Radiol. 2000;35:25-34. [PMID: 10639033 DOI: 10.1097/00004424-200001000-00003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 3.4] [Reference Citation Analysis]
90 Namkung S, Zech CJ, Helmberger T, Reiser MF, Schoenberg SO. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. J Magn Reson Imaging 2007;25:755-65. [PMID: 17335040 DOI: 10.1002/jmri.20873] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
91 Ishida T, Murakami T, Kato N, Takahashi M, Miyazawa T, Tsuda K, Tomoda K, Narumi Y, Nakamura H. Superparamagnetic Iron Oxide Enhanced Magnetic Resonance Imaging of Rat Liver with Hepatocellular Carcinoma and Benign Hyperplastic Nodule: . INVESTIGATIVE RADIOLOGY 1997;32:282-7. [DOI: 10.1097/00004424-199705000-00005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
92 Ichihashi S, Marugami N, Tanaka T, Iwakoshi S, Kurumatani N, Kitano S, Nogi A, Kichikawa K. Preliminary experience with superparamagnetic iron oxide-enhanced dynamic magnetic resonance imaging and comparison with contrast-enhanced computed tomography in endoleak detection after endovascular aneurysm repair. Journal of Vascular Surgery 2013;58:66-72. [DOI: 10.1016/j.jvs.2012.12.061] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
93 Lee H, Shin TH, Cheon J, Weissleder R. Recent Developments in Magnetic Diagnostic Systems. Chem Rev 2015;115:10690-724. [PMID: 26258867 DOI: 10.1021/cr500698d] [Cited by in Crossref: 173] [Cited by in F6Publishing: 135] [Article Influence: 24.7] [Reference Citation Analysis]
94 Kanematsu M, Matsuo M, Yamada Y, Semelka RC, Kondo H, Goshima S, Hoshi H, Moriyama N. Perilesional hyperintense rim of malignant hepatic tumors on ferumoxide-enhanced T1-weighted gradient-echo MR images: correlation between MR imaging and histopathologic findings. J Magn Reson Imaging 2003;18:40-8. [PMID: 12815638 DOI: 10.1002/jmri.10328] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
95 Ma HL, Xu YF, Qi XR, Maitani Y, Nagai T. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int J Pharm. 2008;354:217-226. [PMID: 18191350 DOI: 10.1016/j.ijpharm.2007.11.036] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
96 Hahn PF, Saini S. Liver-specific MR imaging contrast agents. Radiol Clin North Am. 1998;36:287-297. [PMID: 9520982 DOI: 10.1016/s0033-8389(05)70022-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
97 Kim SJ, Kim SH, Lee J, Chang S, Kim Y, Kim SH, Jeon YH, Choi D. Ferucarbotran-Enhanced 3.0-T Magnetic Resonance Imaging Using Parallel Imaging Technique Compared With Triple-Phase Multidetector Row Computed Tomography for the Preoperative Detection of Hepatocellular Carcinoma: . Journal of Computer Assisted Tomography 2008;32:379-85. [DOI: 10.1097/rct.0b013e3180de5c80] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
98 Chen D, Sun N, Gu H. Size analysis of carboxydextran coated superparamagnetic iron oxide particles used as contrast agents of magnetic resonance imaging. Journal of Applied Physics 2009;106:063906. [DOI: 10.1063/1.3211307] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
99 Onishi H, Murakami T, Kim T, Hori M, Hirohashi S, Matsuki M, Narumi Y, Imai Y, Sakurai K, Nakamura H. Safety of ferucarbotran in MR imaging of the liver: a pre- and postexamination questionnaire-based multicenter investigation. J Magn Reson Imaging 2009;29:106-11. [PMID: 19097079 DOI: 10.1002/jmri.21608] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
100 Metz S, Beer AJ, Settles M, Pelisek J, Botnar RM, Rummeny EJ, Heider P. Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. Int J Cardiovasc Imaging 2011;27:901-12. [PMID: 20972832 DOI: 10.1007/s10554-010-9736-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
101 Woltz S, Rüssel C. Self organized nano crystallinity of magnetite precipitated from a 4.9Na2O·33.3CaO·17.1Fe2O3·44.7B2O3 glass. Journal of Non-Crystalline Solids 2004;337:226-31. [DOI: 10.1016/j.jnoncrysol.2004.04.015] [Cited by in Crossref: 39] [Article Influence: 2.2] [Reference Citation Analysis]
102 Talebloo N, Gudi M, Robertson N, Wang P. Magnetic Particle Imaging: Current Applications in Biomedical Research. J Magn Reson Imaging 2020;51:1659-68. [PMID: 31332868 DOI: 10.1002/jmri.26875] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
103 Matsuo M, Kanematsu M, Inaba Y, Matsueda K, Yamagami T, Kondo H, Arai Y, Hoshi H. Pre-operative detection of malignant hepatic tumours: value of combined helical CT during arterial portography and biphasic CT during hepatic arteriography. Clin Radiol. 2001;56:138-145. [PMID: 11222073 DOI: 10.1053/crad.2000.0593] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
104 Scott J, Ward J, Guthrie J, Wilson D, Robinson P. MRI of liver: a comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases. Magnetic Resonance Imaging 2000;18:297-303. [DOI: 10.1016/s0730-725x(00)00116-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
105 Reimer P, Schuierer G, Balzer T, Peters PE. Application of a superparamagnetic iron oxide (Resovis®) for MR imaging of human cerebral blood volume. Magn Reson Med 1995;34:694-7. [DOI: 10.1002/mrm.1910340507] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
106 Garg D, Kaur M, Sharma S, Verma V. Effect of CTAB coating on structural, magnetic and peroxidase mimic activity of ferric oxide nanoparticles. Bull Mater Sci 2018;41. [DOI: 10.1007/s12034-018-1650-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
107 García I, Gallo J, Genicio N, Padro D, Penadés S. Magnetic glyconanoparticles as a versatile platform for selective immunolabeling and imaging of cells. Bioconjug Chem 2011;22:264-73. [PMID: 21247095 DOI: 10.1021/bc1003923] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
108 Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology. 2005;237:520-528. [PMID: 16192317 DOI: 10.1148/radiol.2372041183] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
109 Okada M, Imai Y, Kim T, Kogita S, Takamura M, Kumano S, Onishi H, Hori M, Fukuda K, Hayashi N. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2010;32:903-913. [PMID: 20882621 DOI: 10.1002/jmri.22333] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
110 Chouhan RS, Horvat M, Ahmed J, Alhokbany N, Alshehri SM, Gandhi S. Magnetic Nanoparticles-A Multifunctional Potential Agent for Diagnosis and Therapy. Cancers (Basel) 2021;13:2213. [PMID: 34062991 DOI: 10.3390/cancers13092213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
111 Barrefelt Å, Paradossi G, Asem H, Margheritelli S, Saghafian M, Oddo L, Muhammed M, Aspelin P, Hassan M, Brismar TB. DYNAMIC MR IMAGING, BIODISTRIBUTION AND PHARMACOKINETICS OF POLYMER SHELLED MICROBUBBLES CONTAINING SPION. NANO 2014;09:1450069. [DOI: 10.1142/s1793292014500696] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
112 Lee HY, Lee SH, Xu C, Xie J, Lee JH, Wu B, Koh AL, Wang X, Sinclair R, Wang SX, Nishimura DG, Biswal S, Sun S, Cho SH, Chen X. Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology 2008;19:165101. [PMID: 21394237 DOI: 10.1088/0957-4484/19/16/165101] [Cited by in Crossref: 86] [Cited by in F6Publishing: 66] [Article Influence: 6.1] [Reference Citation Analysis]
113 Gallo J, García I, Padro D, Arnáiz B, Penadés S. Water-soluble magnetic glyconanoparticles based on metal-doped ferrites coated with gold: Synthesis and characterization. J Mater Chem 2010;20:10010. [DOI: 10.1039/c0jm01756f] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
114 Chou CT, Chen RC, Chen WT, Lii JM. Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI. Br J Radiol 2010;83:1023-8. [PMID: 20413445 DOI: 10.1259/bjr/21476692] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]